Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 9 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

22%

2 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

9Total
Not Applicable (7)
P 4 (2)

Trial Status

Completed5
Not Yet Recruiting2
Active Not Recruiting1
Enrolling By Invitation1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (9)

Research Network

Activity Timeline